These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1506866)

  • 1. MRI findings of multiple sclerosis with acute transverse myelopathy.
    Fukazawa T; Miyasaka K; Tashiro K; Hamada T; Moriwaka F; Yanagihara T; Hamada K
    J Neurol Sci; 1992 Jul; 110(1-2):27-31. PubMed ID: 1506866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute transverse myelopathy in multiple sclerosis: clinical and laboratory analyses.
    Fukazawa T
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):79-95. PubMed ID: 8444406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study.
    Godoy AJ; Kira J; Hasuo K; Goto I
    J Neurol Sci; 1995 Nov; 133(1-2):102-11. PubMed ID: 8583211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute transverse myelopathy in multiple sclerosis.
    Fukazawa T; Hamada T; Tashiro K; Moriwaka F; Yanagihara T
    J Neurol Sci; 1990 Dec; 100(1-2):217-22. PubMed ID: 2089136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topological characteristics of brainstem lesions in clinically definite and clinically probable cases of multiple sclerosis: an MRI-study.
    Brainin M; Reisner T; Neuhold A; Omasits M; Wicke L
    Neuroradiology; 1987; 29(6):530-4. PubMed ID: 3431697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study.
    Ormerod IE; Miller DH; McDonald WI; du Boulay EP; Rudge P; Kendall BE; Moseley IF; Johnson G; Tofts PS; Halliday AM
    Brain; 1987 Dec; 110 ( Pt 6)():1579-616. PubMed ID: 3427402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Initial manifestation of disseminated encephalomyelitis: MRT comparative study with established disseminated encephalomyelitis].
    Baum K; Girke W; Bräu H; Schörner W; Felix R
    Nervenarzt; 1986 Aug; 57(8):455-60. PubMed ID: 3748241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features.
    Koopmans RA; Li DK; Grochowski E; Cutler PJ; Paty DW
    Ann Neurol; 1989 Jan; 25(1):74-81. PubMed ID: 2913931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of qualitative and quantitative MRI assessment of multiple sclerosis lesions according to their in evaluating the efficacy of intravenous immunoglobulin G.
    Koçer B; Yildirim-Gürel S; Tali ET; Irkeç C; Işik S
    Neuroradiology; 2004 Apr; 46(4):287-90. PubMed ID: 15007574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients.
    Renard D; Castelnovo G; Bousquet PJ; de Champfleur N; de Seze J; Vermersch P; Labauge P
    Clin Neurol Neurosurg; 2010 May; 112(4):286-90. PubMed ID: 20061078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial vs sagittal T2-weighted brain MR images in the evaluation of multiple sclerosis.
    Wilms G; Marchal G; Kersschot E; Vanhoenacker P; Demaerel P; Bosmans H; Carton H; Baert AL
    J Comput Assist Tomogr; 1991; 15(3):359-64. PubMed ID: 2026793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms.
    Iannucci G; Minicucci L; Rodegher M; Sormani MP; Comi G; Filippi M
    J Neurol Sci; 1999 Dec; 171(2):121-9. PubMed ID: 10581378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating MR lesions and functional deficits in multiple sclerosis patients. Anatomical atlas registration.
    Gardner JC; Yazdani F
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):569-86, vi. PubMed ID: 9894110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MRI and the diagnosis of multiple sclerosis].
    Lyrer P; Groebke-Lorenz W; Benz UF; Wüthrich R
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1849-53. PubMed ID: 2609142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.
    Harrison DM; Oh J; Roy S; Wood ET; Whetstone A; Seigo MA; Jones CK; Pham D; van Zijl P; Reich DS; Calabresi PA
    Mult Scler; 2015 Aug; 21(9):1139-50. PubMed ID: 25583851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in a multiple sclerosis patient with progressive ataxia.
    Lu CS; Liu HM
    J Formos Med Assoc; 1994 Oct; 93(10):879-81. PubMed ID: 7749343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.
    Geurts JJ; Pouwels PJ; Uitdehaag BM; Polman CH; Barkhof F; Castelijns JA
    Radiology; 2005 Jul; 236(1):254-60. PubMed ID: 15987979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
    Thompson AJ; Kermode AG; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; McDonald WI
    BMJ; 1990 Mar; 300(6725):631-4. PubMed ID: 2138923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    Calabrese M; Reynolds R; Magliozzi R; Castellaro M; Morra A; Scalfari A; Farina G; Romualdi C; Gajofatto A; Pitteri M; Benedetti MD; Monaco S
    PLoS One; 2015; 10(8):e0135428. PubMed ID: 26267665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.